retatrutide parkinson's disease clinical trial therapies in the pipeline: a 10-year retrospective analysis Is it time to repurpose

Second, DPP4 degrades both GLP-1 and gastric inhibitory polypeptide (GIP), yet metformin treatment in humans only increases the GLP-1 concentration, whereas DPP4 inhibitors increase both GLP-1 and GIP concentrations [60, 61]

Oncologist Coral Omene at Rutgers Cancer Institute, for example, plans to follow 40 breast cancer patients starting tirzepatide, a GLP-1 drug sold under the brand names Mounjaro and Zepbound

This is the kind of decision that requires a physician seeing your labs and your response over time, not a fixed schedule from a forum

Xie et al

That projection should be read cautiously, but it's useful because it corrects a common misunderstanding

has acted as a consultant of Medtronic, Novo Nordisk and Sanofi and received speaking fees from Abbott, Eli Lilly, Medtronic, MOVI, Novo Nordisk and Sanofi